Patent Case Watch

Patent opinions from the Eastern District of Texas and the U.S. Court of Appeals for the Federal Circuit

Fed. Cir.

INO Therapeutics LLC v. Praxair Distribution Inc., No. 18-1019 (Fed. Cir. Aug. 27, 2019)

Affirmed in Part
§ 101 Eligibility Non-Infringement
Court
U.S. Court of Appeals for the Federal Circuit
Case No.
No. 18-1019
Decided
August 27, 2019
Judge
Prost, C.J.
Document
Nonprecedential Opinion
Length
34 pages

From the Opinion

The passage below is extracted verbatim from the opening of the document. It has not been editorially summarized — consult the full opinion for the court's complete reasoning.

INO Therapeutics LLC , Mallinckrodt Hospital Prod- ucts Inc., and Mallinckrodt Hospital Products IP Ltd. (col- lectively, “ Mallinckrodt”) sued Praxair Distribution Inc. and Praxair Inc. (collectively, “Praxair”) for patent in- fringement. Mallinckrodt asserted five patents related to methods of administering i nhaled nitric oxide , including U.S. Patent Nos.

Download Opinion (PDF)

Source: govinfo.gov USCOURTS collection · retrieved July 23, 2026 · Report an error